Lexicon Pharmaceuticals, Inc.
LXRX
$0.3918
$0.02416.55%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -16.65% | -12.83% | 109.14% | -22.16% | -14.92% |
| Total Receivables | 10.50% | 71.69% | 51.09% | 217.61% | -53.58% |
| Inventory | 8.72% | 13.81% | 34.91% | 13.39% | 95.35% |
| Prepaid Expenses | -12.63% | 9.50% | 36.63% | 19.55% | -29.93% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -16.28% | -12.01% | 106.54% | -20.96% | -15.30% |
|
|
|||||
| Total Current Assets | -16.28% | -12.01% | 106.54% | -20.96% | -15.30% |
| Net Property, Plant & Equipment | 0.07% | -0.83% | -4.13% | -3.96% | -7.56% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 11.44% | -- |
| Total Assets | -13.99% | -10.51% | 81.85% | -17.02% | -12.71% |
|
|
|||||
| Total Accounts Payable | 16.21% | 51.48% | -43.94% | 19.55% | 14.62% |
| Total Accrued Expenses | 43.01% | 2.31% | -11.50% | -16.20% | 32.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.77% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 29.31% | 19.13% | -25.83% | -2.22% | 23.56% |
|
|
|||||
| Total Current Liabilities | 29.31% | 19.13% | -25.83% | -2.22% | 23.56% |
| Long-Term Debt | 0.40% | -0.38% | 0.37% | 0.24% | 0.50% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.28% | -3.80% | -3.53% | -3.27% | -0.71% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 78.74% | -- | -- | -- | -- |
| Total Liabilities | 6.92% | 3.91% | -5.84% | -0.47% | 5.07% |
|
|
|||||
| Common Stock & APIC | 0.13% | 0.22% | 13.20% | 0.17% | 0.20% |
| Retained Earnings | -3.47% | -2.94% | -2.74% | -2.90% | -3.03% |
| Treasury Stock & Other | 11.27% | -3.07% | -63.45% | 4.80% | -0.44% |
| Total Common Equity | -25.61% | -16.92% | 210.22% | -33.26% | -25.14% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -25.61% | -16.92% | 210.22% | -33.26% | -25.14% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -25.61% | -16.92% | 210.24% | -33.26% | -25.14% |
|
|
|||||
